Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,284 public trials 3,242 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Terminated

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

NCT05435014

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Tungs' Taichung Metroharbor Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Terminated

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

NCT05199285

Conditions
Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +19 more
Locations
  • University of Alabama- Birmingham Birmingham, Alabama, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Terminated

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

NCT03281369

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Uni of Southern California Los Angeles, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • Columbia University Medical Center New York, United States
View all 28 locations
View Trial Details
Suspended

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

NCT06102902

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 15 locations
View Trial Details

Related conditions